Ann: AnteoTech Secures $3.76M Option Underwriting Agreement, page-3

“I can confirm that we are making excellent progress on the Proof of Concept COVID-19 Antigen Rapid Test and engagement from the academic, scientific, government and corporate sectors has been very encouraging. We are pushing ahead with the next stages of development and we
expect to report on more results very soon."

“With a clear development pathway in place and the funding support to drive this now secured, we are exceptionally well positioned to deliver significant value over the coming months, and I look forward to providing shareholders with regular updates.”